<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-27T05:36:05Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/34419" metadataPrefix="mods">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/34419</identifier><datestamp>2026-02-03T11:35:54Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37953</setSpec></header><metadata><mods:mods xmlns:doc="http://www.lyncode.com/xoai" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
   <mods:name>
      <mods:namePart>Matas-Rico, Elisa</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>van Veen, Wouter H</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Leyton-Puig, Daniela</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>van den Berg, Jeroen</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Koster, Jan</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Kedziora, Katarzyna M</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Molenaar, Bas</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>J A Weerts, Marjolein</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>de Rink, Iris</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Medema, René H</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Giepmans, Ben N G</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Perrakis, Anastassis</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Jalink, Kees</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Versteeg, Rogier</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>van Veen</mods:namePart>
   </mods:name>
   <mods:extension>
      <mods:dateAvailable encoding="iso8601">2024-10-07T09:59:50Z</mods:dateAvailable>
   </mods:extension>
   <mods:extension>
      <mods:dateAccessioned encoding="iso8601">2024-10-07T09:59:50Z</mods:dateAccessioned>
   </mods:extension>
   <mods:originInfo>
      <mods:dateIssued encoding="iso8601">2016-10</mods:dateIssued>
   </mods:originInfo>
   <mods:identifier type="citation">Elisa Matas-Rico, Michiel van Veen, Daniela Leyton-Puig, Jeroen van den Berg, Jan Koster, Katarzyna M. Kedziora, Bas Molenaar, Marjolein J.A. Weerts, Iris de Rink, René H. Medema, Ben N.G. Giepmans, Anastassis Perrakis, Kees Jalink, Rogier Versteeg, Wouter H. Moolenaar, Glycerophosphodiesterase GDE2 Promotes Neuroblastoma Differentiation through Glypican Release and Is a Marker of Clinical Outcome, Cancer Cell, Volume 30, Issue 4, 2016, Pages 548-562, ISSN 1535-6108, https://doi.org/10.1016/j.ccell.2016.08.016.</mods:identifier>
   <mods:identifier type="uri">https://hdl.handle.net/10630/34419</mods:identifier>
   <mods:identifier type="doi">10.1016/j.ccell.2016.08.016</mods:identifier>
   <mods:abstract>Neuroblastoma is a pediatric embryonal malignancy characterized by impaired neuronal differentiation.&#xd;
A better understanding of neuroblastoma differentiation is essential for developing new therapeutic&#xd;
approaches. GDE2 (encoded by GDPD5) is a six-transmembrane-domain glycerophosphodiesterase&#xd;
that promotes embryonic neurogenesis. We find that high GDPD5 expression is strongly associated&#xd;
with favorable outcome in neuroblastoma. GDE2 induces differentiation of neuroblastoma cells, suppresses cell motility, and opposes RhoA-driven neurite retraction. GDE2 alters the Rac-RhoA activity&#xd;
balance and the expression of multiple differentiation-associated genes. Mechanistically, GDE2 acts&#xd;
by cleaving (in cis) and releasing glycosylphosphatidylinositol-anchored glypican-6, a putative co-receptor. A single point mutation in the ectodomain abolishes GDE2 function. Our results reveal GDE2&#xd;
as a cell-autonomous inducer of neuroblastoma differentiation with prognostic significance and potential therapeutic value.</mods:abstract>
   <mods:language>
      <mods:languageTerm>eng</mods:languageTerm>
   </mods:language>
   <mods:accessCondition type="useAndReproduction">http://creativecommons.org/licenses/by-nc-nd/4.0/</mods:accessCondition>
   <mods:accessCondition type="useAndReproduction">open access</mods:accessCondition>
   <mods:accessCondition type="useAndReproduction">Attribution-NonCommercial-NoDerivatives 4.0 Internacional</mods:accessCondition>
   <mods:subject>
      <mods:topic>Neuroblastoma</mods:topic>
   </mods:subject>
   <mods:titleInfo>
      <mods:title>Glycerophosphodiesterase GDE2 Promotes Neuroblastoma Differentiation through Glypican Release and Is a Marker of Clinical Outcome</mods:title>
   </mods:titleInfo>
   <mods:genre>journal article</mods:genre>
</mods:mods>
</metadata></record></GetRecord></OAI-PMH>